Biomedical Prevention of HIV Research Education (R25)

archived

Purpose: This FOA issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), solicits Research Education Grant (R25) applications from institutions/organizations that propose to create a supportive environment nationwide in the United States for participation in biomedical HIV prevention trials. The program will support innovative, evidence-based approaches to educate and engage U.S. populations most highly affected by HIV and AIDS (see http://www.cdc.gov/hiv/topics/surveillance/index.htm for more information) about clinical biomedical prevention research. This FOA will provide support for the formation of partnerships on a national scale among scientists, educators, media experts, community leaders, and other members of stakeholder organizations to enhance knowledge and understanding within highly HIV-affected communities of clinical biomedical HIV prevention research. Clinical biomedical HIV prevention research includes but is not limited to HIV vaccine research, microbicide research, pre-exposure prophylaxis research, and research on test and treat strategies for reducing HIV incidence. Mechanism of Support: This FOA will use the NIH Research Education (R25) grant mechanism. Research education programs may not be transferred from one institution to another, unless strongly justified (see Section VI.2). Funds Available and Anticipated Number of Awards: The NIAID intends to commit up to $1.8M in total funding in FY2011 to fund one award in response to this FOA. An award issued under this FOA is contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

High